vs

Side-by-side financial comparison of Spectral AI, Inc. (MDAI) and Valaris Ltd (VAL). Click either name above to swap in a different company.

Valaris Ltd is the larger business by last-quarter revenue ($5.2M vs $4.1M, roughly 1.3× Spectral AI, Inc.). Valaris Ltd runs the higher net margin — 13798.1% vs 25.7%, a 13772.3% gap on every dollar of revenue. On growth, Valaris Ltd posted the faster year-over-year revenue change (405.9% vs -46.3%). Over the past eight quarters, Valaris Ltd's revenue compounded faster (29.5% CAGR vs -19.6%).

Spectral AI, Inc. is a medical technology firm specializing in AI-powered diagnostic imaging solutions primarily for burn and wound care. It develops non-invasive imaging tools that enable healthcare providers to deliver faster, more accurate treatment assessments, serving clinical and healthcare partner networks across North America and European markets.

Valaris Limited is an offshore drilling contractor headquartered in Houston, Texas, and incorporated in Bermuda. It is the largest offshore drilling and well drilling company in the world. As of February 2025, it owned 52 rigs, including 36 offshore jackup rigs, 11 drillships, and 5 semi-submersible platform drilling rigs.

MDAI vs VAL — Head-to-Head

Bigger by revenue
VAL
VAL
1.3× larger
VAL
$5.2M
$4.1M
MDAI
Growing faster (revenue YoY)
VAL
VAL
+452.1% gap
VAL
405.9%
-46.3%
MDAI
Higher net margin
VAL
VAL
13772.3% more per $
VAL
13798.1%
25.7%
MDAI
Faster 2-yr revenue CAGR
VAL
VAL
Annualised
VAL
29.5%
-19.6%
MDAI

Income Statement — Q4 FY2025 vs Q4 FY2025

Metric
MDAI
MDAI
VAL
VAL
Revenue
$4.1M
$5.2M
Net Profit
$1.1M
$717.5M
Gross Margin
45.2%
-7850.0%
Operating Margin
-54.9%
Net Margin
25.7%
13798.1%
Revenue YoY
-46.3%
405.9%
Net Profit YoY
113.9%
436.6%
EPS (diluted)
$0.04
$10.13

Green = leading value per metric. Periods may differ when fiscal calendars don't align.

8-Quarter Revenue & Profit Trend

Side-by-side quarterly history. Quarters aligned by calendar period so offset fiscal years line up.

Revenue
MDAI
MDAI
VAL
VAL
Q4 25
$4.1M
$5.2M
Q3 25
$3.8M
$5.6M
Q2 25
$5.1M
$700.0K
Q1 25
$6.7M
Q4 24
$7.6M
$-1.7M
Q3 24
$8.2M
$3.9M
Q2 24
$7.5M
$4.8M
Q1 24
$6.3M
$2.6M
Net Profit
MDAI
MDAI
VAL
VAL
Q4 25
$1.1M
$717.5M
Q3 25
$-3.6M
$188.1M
Q2 25
$-8.0M
$115.1M
Q1 25
$2.9M
Q4 24
$-7.6M
$133.7M
Q3 24
$-1.5M
$64.6M
Q2 24
$-2.9M
$149.6M
Q1 24
$-3.2M
$25.5M
Gross Margin
MDAI
MDAI
VAL
VAL
Q4 25
45.2%
-7850.0%
Q3 25
42.7%
-7142.9%
Q2 25
45.2%
-56428.6%
Q1 25
47.2%
Q4 24
44.0%
24529.4%
Q3 24
44.9%
-11748.7%
Q2 24
44.3%
-9039.6%
Q1 24
46.6%
-17007.7%
Operating Margin
MDAI
MDAI
VAL
VAL
Q4 25
-54.9%
Q3 25
-88.1%
Q2 25
-41.9%
Q1 25
-13.4%
Q4 24
-14.6%
Q3 24
-10.8%
Q2 24
-32.7%
Q1 24
-33.9%
Net Margin
MDAI
MDAI
VAL
VAL
Q4 25
25.7%
13798.1%
Q3 25
-93.7%
3358.9%
Q2 25
-157.3%
16442.9%
Q1 25
43.2%
Q4 24
-99.8%
-7864.7%
Q3 24
-18.4%
1656.4%
Q2 24
-38.3%
3116.7%
Q1 24
-50.7%
980.8%
EPS (diluted)
MDAI
MDAI
VAL
VAL
Q4 25
$0.04
$10.13
Q3 25
$-0.13
$2.65
Q2 25
$-0.31
$1.61
Q1 25
$0.11
Q4 24
$-0.42
$1.86
Q3 24
$-0.08
$0.88
Q2 24
$-0.16
$2.03
Q1 24
$-0.19
$0.35

Balance Sheet & Financial Strength

Snapshot of each company's liquidity, leverage and book value from the latest quarter.

Metric
MDAI
MDAI
VAL
VAL
Cash + ST InvestmentsLiquidity on hand
$15.4M
$599.4M
Total DebtLower is stronger
$9.3M
Stockholders' EquityBook value
$-5.7M
$3.2B
Total Assets
$21.4M
$5.3B
Debt / EquityLower = less leverage

8-quarter trend — quarters aligned by calendar period.

Cash + ST Investments
MDAI
MDAI
VAL
VAL
Q4 25
$15.4M
$599.4M
Q3 25
$10.5M
$662.7M
Q2 25
$10.5M
$503.4M
Q1 25
$14.1M
Q4 24
$5.2M
$368.2M
Q3 24
$3.7M
$379.3M
Q2 24
$6.9M
$398.3M
Q1 24
$10.2M
$494.1M
Total Debt
MDAI
MDAI
VAL
VAL
Q4 25
$9.3M
Q3 25
Q2 25
Q1 25
$7.8M
Q4 24
$2.8M
Q3 24
$1.0M
Q2 24
Q1 24
Stockholders' Equity
MDAI
MDAI
VAL
VAL
Q4 25
$-5.7M
$3.2B
Q3 25
$-8.2M
$2.4B
Q2 25
$-9.2M
$2.3B
Q1 25
$-1.6M
Q4 24
$-7.3M
$2.2B
Q3 24
$-4.8M
$2.1B
Q2 24
$-4.7M
$2.2B
Q1 24
$-2.5M
$2.0B
Total Assets
MDAI
MDAI
VAL
VAL
Q4 25
$21.4M
$5.3B
Q3 25
$15.3M
$4.6B
Q2 25
$16.0M
$4.5B
Q1 25
$20.7M
Q4 24
$12.1M
$4.4B
Q3 24
$11.6M
$4.3B
Q2 24
$13.9M
$4.4B
Q1 24
$15.5M
$4.4B

Cash Flow & Capital Efficiency

How much cash each business actually produces after reinvestment. Cash flow is harder to manipulate than net income.

Metric
MDAI
MDAI
VAL
VAL
Operating Cash FlowLast quarter
$-2.6M
$72.2M
Free Cash FlowOCF − Capex
$-34.1M
FCF MarginFCF / Revenue
-655.8%
Capex IntensityCapex / Revenue
2044.2%
Cash ConversionOCF / Net Profit
-2.43×
0.10×
TTM Free Cash FlowTrailing 4 quarters
$159.9M

8-quarter trend — quarters aligned by calendar period.

Operating Cash Flow
MDAI
MDAI
VAL
VAL
Q4 25
$-2.6M
$72.2M
Q3 25
$-2.5M
$198.1M
Q2 25
$-3.4M
$120.0M
Q1 25
$-1.5M
Q4 24
$469.0K
$124.6M
Q3 24
$-1.6M
$193.0M
Q2 24
$-5.4M
$11.5M
Q1 24
$-2.7M
$26.3M
Free Cash Flow
MDAI
MDAI
VAL
VAL
Q4 25
$-34.1M
Q3 25
$128.3M
Q2 25
$52.8M
Q1 25
Q4 24
$12.9M
Q3 24
$111.1M
Q2 24
$-98.7M
Q1 24
$-125.0M
FCF Margin
MDAI
MDAI
VAL
VAL
Q4 25
-655.8%
Q3 25
2291.1%
Q2 25
7542.9%
Q1 25
Q4 24
-758.8%
Q3 24
2848.7%
Q2 24
-2056.3%
Q1 24
-4807.7%
Capex Intensity
MDAI
MDAI
VAL
VAL
Q4 25
2044.2%
Q3 25
1246.4%
Q2 25
9600.0%
Q1 25
Q4 24
-6570.6%
Q3 24
2100.0%
Q2 24
2295.8%
Q1 24
5819.2%
Cash Conversion
MDAI
MDAI
VAL
VAL
Q4 25
-2.43×
0.10×
Q3 25
1.05×
Q2 25
1.04×
Q1 25
-0.52×
Q4 24
0.93×
Q3 24
2.99×
Q2 24
0.08×
Q1 24
1.03×

Financial Flow Comparison

Revenue → gross profit → operating profit → net profit for each company.

Related Comparisons